Indole-3-Carbinol Synergizes With and Restores Fludarabine Sensitivity in Chronic Lymphocytic Leukemia Cells Irrespective of P53 Activity and Treatment Resistances

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-0736
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?

Therapeutic Advances in Hematology
Hematology
2015English

P53 and microRNAs in Chronic Lymphocytic Leukemia

Journal of Nucleic Acids Investigation
2011English

Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2016English

Anti-Adult T-Cell Leukemia/Lymphoma Effects of Indole-3-Carbinol

Retrovirology
VirologyInfectious Diseases
2009English

Functional Assessment of P53 in Chronic Lymphocytic Leukemia

Blood Cancer Journal
OncologyHematology
2011English

Cost-Effectiveness of Adding Rituximab to Fludarabine and Cyclophosphamide for Treatment of Chronic Lymphocytic Leukemia in Ukraine

Cancer Management and Research
Oncology
2015English

R-Dhap Is Effective in Fludarabine-Refractory Chronic Lymphocytic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Interdependent Regulation of P53 and miR-34a in Chronic Lymphocytic Leukemia

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2010English

Tumour Lysis Syndrome After Treatment of Chronic Lymphocytic Leukaemia With Fludarabine.

Postgraduate Medical Journal
Medicine
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy